Cargando…

A cross-sectional study of the magnitude, barriers, and outcomes of HIV status disclosure among women participating in a perinatal HIV transmission study, “the Nevirapine Repeat Pregnancy study”

BACKGROUND: HIV status disclosure is a difficult emotional task for HIV-infected persons and may create the opportunity for both social support and rejection. In this study, we evaluated the proportions, patterns, barriers and outcomes of HIV- 1 status disclosure among a group of women in Uganda. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiweewa, Flavia M, Bakaki, Paul M, McConnell, Michelle S, Musisi, Maria, Namirembe, Constance, Nakayiwa, Frances, Kusasira, Fiona, Nakintu, Dorothy, Mubiru, Michael C, Musoke, Philippa, Fowler, Mary Glenn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588248/
https://www.ncbi.nlm.nih.gov/pubmed/26420040
http://dx.doi.org/10.1186/s12889-015-2345-6
_version_ 1782392593086152704
author Kiweewa, Flavia M
Bakaki, Paul M
McConnell, Michelle S
Musisi, Maria
Namirembe, Constance
Nakayiwa, Frances
Kusasira, Fiona
Nakintu, Dorothy
Mubiru, Michael C
Musoke, Philippa
Fowler, Mary Glenn
author_facet Kiweewa, Flavia M
Bakaki, Paul M
McConnell, Michelle S
Musisi, Maria
Namirembe, Constance
Nakayiwa, Frances
Kusasira, Fiona
Nakintu, Dorothy
Mubiru, Michael C
Musoke, Philippa
Fowler, Mary Glenn
author_sort Kiweewa, Flavia M
collection PubMed
description BACKGROUND: HIV status disclosure is a difficult emotional task for HIV-infected persons and may create the opportunity for both social support and rejection. In this study, we evaluated the proportions, patterns, barriers and outcomes of HIV- 1 status disclosure among a group of women in Uganda. METHODS: An exit interview was conducted one year post-partum for 85 HIV-infected women who participated in a study of HIV-1 transmission rates among NVP-experienced compared with NVP-naïve women in “The Nevirapine Repeat Pregnancy (NVP-RP) Study” at the Makerere University-Johns Hopkins University Research Collaboration, Kampala-Uganda, between June 2004 and June 2006. RESULTS: Of the 85 women interviewed, 99 % had disclosed their HIV status to at least one other person. Disclosure proportions ranged between 1 % to employer(s) and 69 % to a relative other than a parent. Only 38 % of the women had disclosed to their sex partners. Women with an HIV-infected baby were more likely than those with an uninfected baby to disclose to their sex partner, OR 4.9 (95 % CI, 2.0 –11.2), and women were less likely to disclose to a partner if they had previously disclosed to another relative than if they had not, OR 0.19 (95 % CI, 0.14–0.52). The most common reasons for non-disclosure included fear of separation from the partner and subsequent loss of financial support 34 %, and not living with the partner (not having opportunities to disclose) 26 %. While most women (67 %) reported getting social support following disclosure, 22 % reported negative outcomes (neglect, separation from their partners, and loss of financial support). Following disclosure of HIV status, 9 % of women reported that their partner (s) decided to have an HIV test. CONCLUSION: Results from this study show high overall HIV disclosure proportions and how this disclosure of HIV status can foster social support. However, proportions of disclosure specifically to male sex partners were low, which suggests the need for interventions aimed at increasing male involvement in perinatal care, along with supportive counseling.
format Online
Article
Text
id pubmed-4588248
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45882482015-10-01 A cross-sectional study of the magnitude, barriers, and outcomes of HIV status disclosure among women participating in a perinatal HIV transmission study, “the Nevirapine Repeat Pregnancy study” Kiweewa, Flavia M Bakaki, Paul M McConnell, Michelle S Musisi, Maria Namirembe, Constance Nakayiwa, Frances Kusasira, Fiona Nakintu, Dorothy Mubiru, Michael C Musoke, Philippa Fowler, Mary Glenn BMC Public Health Research Article BACKGROUND: HIV status disclosure is a difficult emotional task for HIV-infected persons and may create the opportunity for both social support and rejection. In this study, we evaluated the proportions, patterns, barriers and outcomes of HIV- 1 status disclosure among a group of women in Uganda. METHODS: An exit interview was conducted one year post-partum for 85 HIV-infected women who participated in a study of HIV-1 transmission rates among NVP-experienced compared with NVP-naïve women in “The Nevirapine Repeat Pregnancy (NVP-RP) Study” at the Makerere University-Johns Hopkins University Research Collaboration, Kampala-Uganda, between June 2004 and June 2006. RESULTS: Of the 85 women interviewed, 99 % had disclosed their HIV status to at least one other person. Disclosure proportions ranged between 1 % to employer(s) and 69 % to a relative other than a parent. Only 38 % of the women had disclosed to their sex partners. Women with an HIV-infected baby were more likely than those with an uninfected baby to disclose to their sex partner, OR 4.9 (95 % CI, 2.0 –11.2), and women were less likely to disclose to a partner if they had previously disclosed to another relative than if they had not, OR 0.19 (95 % CI, 0.14–0.52). The most common reasons for non-disclosure included fear of separation from the partner and subsequent loss of financial support 34 %, and not living with the partner (not having opportunities to disclose) 26 %. While most women (67 %) reported getting social support following disclosure, 22 % reported negative outcomes (neglect, separation from their partners, and loss of financial support). Following disclosure of HIV status, 9 % of women reported that their partner (s) decided to have an HIV test. CONCLUSION: Results from this study show high overall HIV disclosure proportions and how this disclosure of HIV status can foster social support. However, proportions of disclosure specifically to male sex partners were low, which suggests the need for interventions aimed at increasing male involvement in perinatal care, along with supportive counseling. BioMed Central 2015-09-29 /pmc/articles/PMC4588248/ /pubmed/26420040 http://dx.doi.org/10.1186/s12889-015-2345-6 Text en © Kiweewa et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Kiweewa, Flavia M
Bakaki, Paul M
McConnell, Michelle S
Musisi, Maria
Namirembe, Constance
Nakayiwa, Frances
Kusasira, Fiona
Nakintu, Dorothy
Mubiru, Michael C
Musoke, Philippa
Fowler, Mary Glenn
A cross-sectional study of the magnitude, barriers, and outcomes of HIV status disclosure among women participating in a perinatal HIV transmission study, “the Nevirapine Repeat Pregnancy study”
title A cross-sectional study of the magnitude, barriers, and outcomes of HIV status disclosure among women participating in a perinatal HIV transmission study, “the Nevirapine Repeat Pregnancy study”
title_full A cross-sectional study of the magnitude, barriers, and outcomes of HIV status disclosure among women participating in a perinatal HIV transmission study, “the Nevirapine Repeat Pregnancy study”
title_fullStr A cross-sectional study of the magnitude, barriers, and outcomes of HIV status disclosure among women participating in a perinatal HIV transmission study, “the Nevirapine Repeat Pregnancy study”
title_full_unstemmed A cross-sectional study of the magnitude, barriers, and outcomes of HIV status disclosure among women participating in a perinatal HIV transmission study, “the Nevirapine Repeat Pregnancy study”
title_short A cross-sectional study of the magnitude, barriers, and outcomes of HIV status disclosure among women participating in a perinatal HIV transmission study, “the Nevirapine Repeat Pregnancy study”
title_sort cross-sectional study of the magnitude, barriers, and outcomes of hiv status disclosure among women participating in a perinatal hiv transmission study, “the nevirapine repeat pregnancy study”
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588248/
https://www.ncbi.nlm.nih.gov/pubmed/26420040
http://dx.doi.org/10.1186/s12889-015-2345-6
work_keys_str_mv AT kiweewaflaviam acrosssectionalstudyofthemagnitudebarriersandoutcomesofhivstatusdisclosureamongwomenparticipatinginaperinatalhivtransmissionstudythenevirapinerepeatpregnancystudy
AT bakakipaulm acrosssectionalstudyofthemagnitudebarriersandoutcomesofhivstatusdisclosureamongwomenparticipatinginaperinatalhivtransmissionstudythenevirapinerepeatpregnancystudy
AT mcconnellmichelles acrosssectionalstudyofthemagnitudebarriersandoutcomesofhivstatusdisclosureamongwomenparticipatinginaperinatalhivtransmissionstudythenevirapinerepeatpregnancystudy
AT musisimaria acrosssectionalstudyofthemagnitudebarriersandoutcomesofhivstatusdisclosureamongwomenparticipatinginaperinatalhivtransmissionstudythenevirapinerepeatpregnancystudy
AT namirembeconstance acrosssectionalstudyofthemagnitudebarriersandoutcomesofhivstatusdisclosureamongwomenparticipatinginaperinatalhivtransmissionstudythenevirapinerepeatpregnancystudy
AT nakayiwafrances acrosssectionalstudyofthemagnitudebarriersandoutcomesofhivstatusdisclosureamongwomenparticipatinginaperinatalhivtransmissionstudythenevirapinerepeatpregnancystudy
AT kusasirafiona acrosssectionalstudyofthemagnitudebarriersandoutcomesofhivstatusdisclosureamongwomenparticipatinginaperinatalhivtransmissionstudythenevirapinerepeatpregnancystudy
AT nakintudorothy acrosssectionalstudyofthemagnitudebarriersandoutcomesofhivstatusdisclosureamongwomenparticipatinginaperinatalhivtransmissionstudythenevirapinerepeatpregnancystudy
AT mubirumichaelc acrosssectionalstudyofthemagnitudebarriersandoutcomesofhivstatusdisclosureamongwomenparticipatinginaperinatalhivtransmissionstudythenevirapinerepeatpregnancystudy
AT musokephilippa acrosssectionalstudyofthemagnitudebarriersandoutcomesofhivstatusdisclosureamongwomenparticipatinginaperinatalhivtransmissionstudythenevirapinerepeatpregnancystudy
AT fowlermaryglenn acrosssectionalstudyofthemagnitudebarriersandoutcomesofhivstatusdisclosureamongwomenparticipatinginaperinatalhivtransmissionstudythenevirapinerepeatpregnancystudy
AT kiweewaflaviam crosssectionalstudyofthemagnitudebarriersandoutcomesofhivstatusdisclosureamongwomenparticipatinginaperinatalhivtransmissionstudythenevirapinerepeatpregnancystudy
AT bakakipaulm crosssectionalstudyofthemagnitudebarriersandoutcomesofhivstatusdisclosureamongwomenparticipatinginaperinatalhivtransmissionstudythenevirapinerepeatpregnancystudy
AT mcconnellmichelles crosssectionalstudyofthemagnitudebarriersandoutcomesofhivstatusdisclosureamongwomenparticipatinginaperinatalhivtransmissionstudythenevirapinerepeatpregnancystudy
AT musisimaria crosssectionalstudyofthemagnitudebarriersandoutcomesofhivstatusdisclosureamongwomenparticipatinginaperinatalhivtransmissionstudythenevirapinerepeatpregnancystudy
AT namirembeconstance crosssectionalstudyofthemagnitudebarriersandoutcomesofhivstatusdisclosureamongwomenparticipatinginaperinatalhivtransmissionstudythenevirapinerepeatpregnancystudy
AT nakayiwafrances crosssectionalstudyofthemagnitudebarriersandoutcomesofhivstatusdisclosureamongwomenparticipatinginaperinatalhivtransmissionstudythenevirapinerepeatpregnancystudy
AT kusasirafiona crosssectionalstudyofthemagnitudebarriersandoutcomesofhivstatusdisclosureamongwomenparticipatinginaperinatalhivtransmissionstudythenevirapinerepeatpregnancystudy
AT nakintudorothy crosssectionalstudyofthemagnitudebarriersandoutcomesofhivstatusdisclosureamongwomenparticipatinginaperinatalhivtransmissionstudythenevirapinerepeatpregnancystudy
AT mubirumichaelc crosssectionalstudyofthemagnitudebarriersandoutcomesofhivstatusdisclosureamongwomenparticipatinginaperinatalhivtransmissionstudythenevirapinerepeatpregnancystudy
AT musokephilippa crosssectionalstudyofthemagnitudebarriersandoutcomesofhivstatusdisclosureamongwomenparticipatinginaperinatalhivtransmissionstudythenevirapinerepeatpregnancystudy
AT fowlermaryglenn crosssectionalstudyofthemagnitudebarriersandoutcomesofhivstatusdisclosureamongwomenparticipatinginaperinatalhivtransmissionstudythenevirapinerepeatpregnancystudy